Literature DB >> 16390981

Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp.

Mitchell J Schwaber1, Shiri Navon-Venezia, Inna Chmelnitsky, Azita Leavitt, David Schwartz, Yehuda Carmeli.   

Abstract

Forty clinical isolates of Enterobacter spp. were identified as extended-spectrum beta-lactamase (ESBL) producers by disk diffusion. The VITEK 2 Advanced Expert System (AES) identified the ESBL phenotype in only 25 isolates (62.5%), and erroneously reported cephalosporin susceptibility in 11 isolates (28%). Refinements in the AES are required in order to improve ESBL detection in Enterobacter.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16390981      PMCID： PMC1351947          DOI： 10.1128/JCM.44.1.241-243.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Validation of the VITEK2 and the Advance Expert System with a collection of Enterobacteriaceae harboring extended spectrum or inhibitor resistant beta-lactamases.

Authors:  R Cantón; M Pérez-Vázquez; A Oliver; T M Coque; E Loza; F Ponz; F Baquero
Journal:  Diagn Microbiol Infect Dis       Date:  2001 Sep-Oct       Impact factor: 2.803

2.  Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital.

Authors:  C C Sanders; M Peyret; E S Moland; S J Cavalieri; C Shubert; K S Thomson; J M Boeufgras; W E Sanders
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

3.  Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.

Authors:  E Tzelepi; P Giakkoupi; D Sofianou; V Loukova; A Kemeroglou; A Tsakris
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp.

Authors:  Maurine A Leverstein-van Hall; Ad C Fluit; Armand Paauw; Adrienne T A Box; Sylvain Brisse; Jan Verhoef
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

5.  Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests.

Authors:  D M Livermore; M Struelens; J Amorim; F Baquero; J Bille; R Canton; S Henning; S Gatermann; A Marchese; H Mittermayer; C Nonhoff; K J Oakton; F Praplan; H Ramos; G C Schito; J Van Eldere; J Verhaegen; J Verhoef; M R Visser
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

6.  In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART).

Authors:  David L Paterson; Flávia Rossi; Fernando Baquero; Po-Ren Hsueh; Gail L Woods; Vilas Satishchandran; Theresa A Snyder; Charlotte M Harvey; Hedy Teppler; Mark J Dinubile; Joseph W Chow
Journal:  J Antimicrob Chemother       Date:  2005-04-22       Impact factor: 5.790

7.  Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates.

Authors:  Enno Stürenburg; Ingo Sobottka; Heinz-Hubert Feucht; Dietrich Mack; Rainer Laufs
Journal:  Diagn Microbiol Infect Dis       Date:  2003-01       Impact factor: 2.803

8.  Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae.

Authors:  Mitchell J Schwaber; Patti M Raney; J Kamile Rasheed; James W Biddle; Portia Williams; John E McGowan; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

9.  Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.

Authors:  Enno Stürenburg; Ingo Sobottka; Djahesh Noor; Rainer Laufs; Dietrich Mack
Journal:  J Antimicrob Chemother       Date:  2004-05-18       Impact factor: 5.790

10.  Detection of extended spectrum beta-lactamases in the routine clinical microbiology laboratory.

Authors:  P D Midolo; D Matthews; C D Fernandez; T G Kerr
Journal:  Pathology       Date:  2002-08       Impact factor: 5.306
View more
  8 in total

1.  Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates.

Authors:  Teresa Spanu; Maurizio Sanguinetti; Mario Tumbarello; Tiziana D'Inzeo; Barbara Fiori; Brunella Posteraro; Rosaria Santangelo; Roberto Cauda; Giovanni Fadda
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

2.  Metallo-beta-lactamase or extended-spectrum beta-lactamase: a wolf in sheep's clothing.

Authors:  Björn A Espedido; Lee C Thomas; Jonathan R Iredell
Journal:  J Clin Microbiol       Date:  2007-04-04       Impact factor: 5.948

3.  Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.

Authors:  Irith Wiegand; Heinrich K Geiss; Dietrich Mack; Enno Stürenburg; Harald Seifert
Journal:  J Clin Microbiol       Date:  2007-02-07       Impact factor: 5.948

4.  Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium.

Authors:  J Färber; K-A Moder; F Layer; I Tammer; W König; B König
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

Review 5.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

6.  Impact of adopting minimum inhibitory concentration as the determinant of susceptibility to cephalosporins and carbapenems in multi-drug resistant Enterobacteriaceae.

Authors:  M Parta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-13       Impact factor: 3.267

7.  Dominance of CTX-M group 1 beta-lactamase enzymes in ESBL producing E. coli from outpatient urines in neighboring regions of Austria and Italy.

Authors:  Hartwig P Huemer; Angelika Eigentler; Richard Aschbacher; Clara Larcher
Journal:  Wien Klin Wochenschr       Date:  2011-01-21       Impact factor: 1.704

8.  Distribution of blaTEM, blaSHV, and blaCTX-M genes among ESBL-producing P. aeruginosa isolated from Qazvin and Tehran hospitals, Iran.

Authors:  A Peymani; T Naserpour-Farivar; E Zare; K H Azarhoosh
Journal:  J Prev Med Hyg       Date:  2017-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.